Synovial sarcoma: From genetics to genetic-based animal modeling

Clinical Orthopaedics and Related Research

Volumn 466, Issue 9, 2008, Pages 2156-2167

  Haldar, Malay ^a   Randall, R Lor ^a,b   Capecchi, Mario R ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRE RECOMBINASE; CADHERIN; ONCOPROTEIN; REPRESSOR PROTEIN; SS18 PROTEIN, HUMAN; SYNOVIAL SARCOMA X BREAKPOINT PROTEINS; TUMOR PROTEIN;

CLINICAL FEATURE; CONFERENCE PAPER; CYTOGENETICS; GENE EXPRESSION; GENE TRANSLOCATION; GENETICS; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SYNOVIAL SARCOMA; TRANSCRIPTION REGULATION; TUMOR MODEL; ANIMAL; CONNECTIVE TISSUE TUMOR; DISEASE MODEL; DNA MICROARRAY; DRUG SCREENING; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW;

ANIMALS; CADHERINS; DISEASE MODELS, ANIMAL; HUMANS; MICE; MYOBLASTS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SARCOMA, SYNOVIAL; TRANSLOCATION, GENETIC; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 50649097473     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-008-0340-2     Document Type: Conference Paper

References (85)

1. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet. 1997;350:1647-1654.
2. SV Allander PB Illei Y Chen CR Antonescu M Bittner M Ladanyi PS Meltzer 2002 Expression profiling of synovial sarcoma by cDNA microarrays: association of ERBB2, IGFBP2, and ELF3 with epithelial differentiation Am J Pathol 161 1587 1595
3. CR Antonescu A Kawai DH Leung F Lonardo JM Woodruff JH Healey M Ladanyi 2000 Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma Diagn Mol Pathol 9 1 8
4. R Barco LB Hunt AL Frump CB Garcia A Benesh RL Caldwell JE Eid 2007 The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway Mol Biol Cell 18 4003 4012
5. S Birdsall P Osin YJ Lu C Fisher J Shipley 1999 Synovial sarcoma specific translocation associated with both epithelial and spindle cell components Int J Cancer 82 605 608
6. JY Blay I Ray-Coquard L Alberti D Ranchere 2004 Targeting other abnormal signaling pathways in sarcoma: EGFR in synovial sarcomas, PPAR-gamma in liposarcomas Cancer Treat Res 120 151 167
7. D Brett S Whitehouse P Antonson J Shipley C Cooper G Goodwin 1997 The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies Hum Mol Genet 6 1559 1564
8. MR Capecchi 2005 Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century Nat Rev Genet 6 507 512
9. J Clark PJ Rocques AJ Crew S Gill J Shipley AM Chan BA Gusterson CS Cooper 1994 Identification of novel genes, SYT and SSX, involved in the t(X;18)(p11.2;q11.2) translocation found in human synovial sarcoma Nat Genet 7 502 508
10. AJ Crew J Clark C Fisher S Gill R Grimer A Chand J Shipley BA Gusterson CS Cooper 1995 Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma Embo J 14 2333 2340
11. DR de Bruijn NR dos Santos J Thijssen M Balemans S Debernardi B Linder BD Young A van Geurts Kessel 2001 The synovial sarcoma associated protein SYT interacts with the acute leukemia associated protein AF10 Oncogene 20 3281 3289
12. DR de Bruijn E Kater-Baats M Eleveld G Merkx A Van Geurts Kessel 2001 Mapping and characterization of the mouse and human SS18 genes, two human SS18-like genes and a mouse Ss18 pseudogene Cytogenet Cell Genet 92 310 319
13. DR de Bruijn WJ Peters SM de Chuva Sousa Lopes AH van Dijk MP Willemse R Pfundt P de Boer A van Geurts Kessel 2006 Targeted disruption of the synovial sarcoma-associated SS18 gene causes early embryonic lethality and affects PPARBP expression Hum Mol Genet 15 2936 2944
14. DR de Bruijn WJ Peters SM de Sousa Lopes AH van Dijk MP Willemse R Pfundt P de Boer AG van Kessel 2006 Targeted disruption of the synovial sarcoma-associated SS18 gene causes early embryonic lethality and affects PPARBP expression Hum Mol Genet 15 2936 2944
15. DR de Bruijn AH van Dijk MP Willemse AG van Kessel 2008 The C terminus of the synovial sarcoma-associated SSX proteins interacts with the LIM homeobox protein LHX4 Oncogene 27 653 662
16. B de Leeuw M Balemans D Olde Weghuis A. van Geurts Kessel 1995 Identification of two alternative fusion genes, SYT-SSX1 and SYT-SSX2, in t(X;18)(p11.2;q11.2)-positive synovial sarcomas Hum Mol Genet 4 1097 1099
17. O Delattre J Zucman B Plougastel C Desmaze T Melot M Peter H Kovar I Joubert P de Jong G Rouleau 1992 Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours Nature 359 162 165
18. NR dos Santos DR de Bruijn E Kater-Baats AP Otte AG van Kessel 2000 Delineation of the protein domains responsible for SYT, SSX, and SYT-SSX nuclear localization Exp Cell Res 256 192 202
19. NR dos Santos DR de Bruijn AG van Kessel 2001 Molecular mechanisms underlying human synovial sarcoma development Genes Chromosomes Cancer 30 1 14
20. JE Eid AL Kung R Scully DM Livingston 2000 p300 interacts with the nuclear proto-oncoprotein SYT as part of the active control of cell adhesion Cell 102 839 848
21. J Fernebro P Francis P Eden A Borg I Panagopoulos F Mertens J Vallon-Christersson M Akerman A Rydholm HC Bauer N Mandahl M Nilbert 2006 Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma Int J Cancer 118 1165 1172
22. A Ferrari A Gronchi M Casanova C Meazza L Gandola P Collini L Lozza R Bertulli P Olmi PG Casali 2004 Synovial sarcoma: a retrospective analysis of 271 patients of all ages treated at a single institution Cancer 101 627 634
23. AL Folpe RA Schmidt D Chapman AM Gown 1998 Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors Am J Surg Pathol 22 673 682
24. C Fukukawa Y Nakamura T Katagiri 2005 Molecular target therapy for synovial sarcoma Future Oncol 1 805 812
25. L Guillou J Benhattar F Bonichon G Gallagher P Terrier E Stauffer S Somerhausen Nde JJ Michels G Jundt DR Vince S Taylor M Genevay F Collin M Trassard JM Coindre 2004 Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis J Clin Oncol 22 4040 4050
26. AO Gure O Tureci U Sahin S Tsang MJ Scanlan E Jager A Knuth M Pfreundschuh LJ Old YT Chen 1997 a multigene family with several members transcribed in normal testis and human cancer Int J Cancer 72 965 971
27. AO Gure IJ Wei LJ Old YT Chen 2002 The SSX gene family: characterization of 9 complete genes Int J Cancer 101 448 453
28. M Haldar JD Hancock CM Coffin SL Lessnick MR Capecchi 2007 A conditional mouse model of synovial sarcoma: insights into a myogenic origin Cancer Cell 11 375 388
29. H Hibshoosh R Lattes 1997 Immunohistochemical and molecular genetic approaches to soft tissue tumor diagnosis: a primer Semin Oncol 24 515 525
30. H Hiraga T Nojima S Abe H Sawa K Yamashiro S Yamawaki K Kaneda K Nagashima 1998 Diagnosis of synovial sarcoma with the reverse transcriptase-polymerase chain reaction: analyses of 84 soft tissue and bone tumors Diagn Mol Pathol 7 102 110
31. M Ishida S Tanaka M Ohki T Ohta 2004 Transcriptional co-activator activity of SYT is negatively regulated by BRM and Brg1 Genes Cells 9 419 428
32. T Ito M Ouchida S Ito Y Jitsumori Y Morimoto T Ozaki A Kawai H Inoue K Shimizu 2004 SYT, a partner of SYT-SSX oncoprotein in synovial sarcomas, interacts with mSin3A, a component of histone deacetylase complex Lab Invest 84 1484 1490
33. DE Joyner KH Albritton JD Bastar RL Randall 2006 G3139 antisense oligonucleotide directed against antiapoptotic Bcl-2 enhances doxorubicin cytotoxicity in the FU-SY-1 synovial sarcoma cell line J Orthop Res 24 474 480
34. T Kasai S Shimajiri H Hashimoto 2000 Detection of SYT-SSX fusion transcripts in both epithelial and spindle cell areas of biphasic synovial sarcoma using laser capture microdissection Mol Pathol 53 107 110
35. H Kato A Tjernberg W Zhang AN Krutchinsky W An T Takeuchi Y Ohtsuki S Sugano DR de Bruijn BT Chait RG Roeder 2002 SYT associates with human SNF/SWI complexes and the C-terminal region of its fusion partner SSX1 targets histones J Biol Chem 277 5498 5505
36. S Kawaguchi T Wada K Ida Y Sato S Nagoya T Tsukahara S Kimura H Sahara H Ikeda K Shimozawa H Asanuma T Torigoe H Hiraga T Ishii SI Tatezaki N Sato T Yamashita 2005 Phase I vaccination trial of SYT-SSX junction peptide in patients with disseminated synovial sarcoma J Transl Med 3 1
37. A Kawai J Woodruff JH Healey MF Brennan CR Antonescu M Ladanyi 1998 SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma N Engl J Med 338 153 160
38. CA Koch D Anderson MF Moran C Ellis T Pawson 1991 SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins Science 252 668 674
39. M Ladanyi CR Antonescu DH Leung JM Woodruff A Kawai JH Healey MF Brennan JA Bridge JR Neff FG Barr JD Goldsmith JS Brooks JR Goldblum SZ Ali J Shipley CS Cooper C Fisher B Skytting O Larsson 2002 Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients Cancer Res 62 135 140
40. JJ Lewis CR Antonescu DH Leung D Blumberg JH Healey JM Woodruff MF Brennan 2000 Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity J Clin Oncol 18 2087 2094
41. FL Lim M Soulez D Koczan HJ Thiesen JC Knight 1998 A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas Oncogene 17 2013 2018
42. A Llombart-Bosch JA Lopez-Guerrero A Peydro-Olaya 2002 Synovial sarcoma (SS): new perspectives supported by modern technology Arkh Patol 64 39 47
43. JM Lopes JM Nesland JS Reis-Filho R Holm 2002 Differential Ki67 and bcl-2 immunoexpression in solid-glandular and spindle cell components of biphasic synovial sarcoma: a double immunostaining assessment with cytokeratin and vimentin Histopathology 40 464 471
44. T Mancuso A Mezzelani C Riva A Fabbri L Dal Bo G Sampietro P Perego P Casali F Zunino G Sozzi MA Pierotti S Pilotti 2000 Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcoma Lab Invest 80 805 813
45. JF Margolin JR Friedman WK Meyer H Vissing HJ Thiesen FJ Rauscher 3rd 1994 Kruppel-associated boxes are potent transcriptional repression domains Proc Natl Acad Sci USA 91 4509 4513
46. M Miettinen I Virtanen 1984 Synovial sarcoma-a misnomer Am J Pathol 117 18 25
47. T Motoi T Ishida M Kuroda H Horiuchi T Oka K Matsumoto T Nakamura R Machinami 1998 Coexpression of hepatocyte growth factor and c-Met proto-oncogene product in synovial sarcoma Pathol Int 48 769 775
48. JR Mullen GK Zagars 1994 Synovial sarcoma outcome following conservation surgery and radiotherapy Radiother Oncol 33 23 30
49. M Nagai S Tanaka M Tsuda S Endo H Kato H Sonobe A Minami H Hiraga H Nishihara H Sawa K Nagashima 2001 Analysis of transforming activity of human synovial sarcoma-associated chimeric protein SYT-SSX1 bound to chromatin remodeling factor hBRM/hSNF2 alpha Proc Natl Acad Sci USA 98 3843 3848
50. S Nagayama T Katagiri T Tsunoda T Hosaka Y Nakashima N Araki K Kusuzaki T Nakayama T Tsuboyama T Nakamura M Imamura Y Nakamura J Toguchida 2002 Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray Cancer Res 62 5859 5866
51. TO Nielsen FD Hsu JX O'Connell CB Gilks PH Sorensen S Linn RB West CL Liu D Botstein PO Brown M van de Rijn 2003 Tissue microarray validation of epidermal growth factor receptor and SALL2 in synovial sarcoma with comparison to tumors of similar histology Am J Pathol 163 1449 1456
52. TO Nielsen RB West SC Linn O Alter MA Knowling JX O'Connell S Zhu M Fero G Sherlock JR Pollack PO Brown D Botstein M van de Rijn 2002 Molecular characterisation of soft tissue tumours: a gene expression study Lancet 359 1301 1307
53. G Nilsson B Skytting Y Xie B Brodin R Perfekt N Mandahl J Lundeberg M Uhlen O Larsson 1999 The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome Cancer Res 59 3180 3184
54. K O'Byrne WP Steward 1999 The role of chemotherapy in the treatment of adult soft tissue sarcomas Oncology 56 13 23
55. Y Oda A Sakamoto T Satio S Kawauchi Y Iwamoto M Tsuneyoshi 2000 Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma Mod Pathol 13 994 1004
56. I Panagopoulos F Mertens M Isaksson J Limon P Gustafson B Skytting M Akerman R Sciot P Dal Cin I Samson M Iliszko J Ryoe M Debiec-Rychter A Szadowska O Brosjo O Larsson A Rydholm N Mandahl 2001 Clinical impact of molecular and cytogenetic findings in synovial sarcoma Genes Chromosomes Cancer 31 362 372
57. AC Paulino 2004 Synovial sarcoma prognostic factors and patterns of failure Am J Clin Oncol 27 122 127
58. T Pawson GD Gish 1992 SH2 and SH3 domains: from structure to function Cell 71 359 362
59. M Pelmus L Guillou I Hostein G Sierankowski C Lussan JM Coindre 2002 Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases Am J Surg Pathol 26 1434 1440
60. M Perani CJ Ingram CS Cooper MD Garrett GH Goodwin 2003 Conserved SNH domain of the proto-oncoprotein SYT interacts with components of the human chromatin remodelling complexes, while the QPGY repeat domain forms homo-oligomers Oncogene 22 8156 8167
61. PW Pisters SR Patel VG Prieto PF Thall VO Lewis BW Feig KK Hunt AW Yasko PP Lin MG Jacobson MA Burgess RE Pollock GK Zagars RS Benjamin MT Ballo 2004 Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas J Clin Oncol 22 3375 3380
62. D Pretto R Barco J Rivera N Neel MD Gustavson JE Eid 2006 The synovial sarcoma translocation protein SYT-SSX2 recruits beta-catenin to the nucleus and associates with it in an active complex Oncogene 25 3661 3669
63. SA Rosenberg 1984 Prospective randomized trials demonstrating the efficacy of adjuvant chemotherapy in adult patients with soft tissue sarcomas Cancer Treat Rep 68 1067 1078
64. T Saito M Nagai M Ladanyi 2006 SYT-SSX1 and SYT-SSX2 interfere with repression of E-cadherin by snail and slug: a potential mechanism for aberrant mesenchymal to epithelial transition in human synovial sarcoma Cancer Res 66 6919 6927
65. T Saito Y Oda K Kawaguchi T Takahira H Yamamoto K Tanaka S Matsuda A Sakamoto Y Iwamoto M Tsuneyoshi 2004 PTEN and other tumor suppressor gene mutations as secondary genetic alterations in synovial sarcoma Oncol Rep 11 1011 1015
66. T Saito Y Oda A Sakamoto K Kawaguchi K Tanaka S Matsuda S Tamiya Y Iwamoto M Tsuneyoshi 2002 APC mutations in synovial sarcoma J Pathol 196 445 449
67. Y Sato Y Nabeta T Tsukahara Y Hirohashi R Syunsui A Maeda H Sahara H Ikeda T Torigoe S Ichimiya T Wada T Yamashita H Hiraga A Kawai T Ishii N Araki A Myoui S Matsumoto T Umeda S Ishii S Kawaguchi N Sato 2002 Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma J Immunol 169 1611 1618
68. B Sauer N Henderson 1989 Cre-stimulated recombination at loxP-containing DNA sequences placed into the mammalian genome Nucleic Acids Res 17 147 161
69. JM Shipley J Clark AJ Crew S Birdsall PJ Rocques S Gill J Chelly AP Monaco S Abe BA Gusterson 1994 The t(X;18)(p11.2;q11.2) translocation found in human synovial sarcomas involves two distinct loci on the X chromosome Oncogene 9 1447 1453
70. B Skytting G Nilsson B Brodin Y Xie J Lundeberg M Uhlen O Larsson 1999 A novel fusion gene, SYT-SSX4, in synovial sarcoma J Natl Cancer Inst 91 974 975
71. ME Smith C Fisher LS Wilkinson JC Edwards 1995 Synovial sarcoma lack synovial differentiation Histopathology 26 279 281
72. S Smith BR Reeves L Wong C Fisher 1987 A consistent chromosome translocation in synovial sarcoma Cancer Genet Cytogenet 26 179 180
73. M Soulez AJ Saurin PS Freemont JC Knight 1999 SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex Oncogene. 18 2739 2746
74. AJ Spillane R A'Hern IR Judson C Fisher JM Thomas 2000 Synovial sarcoma: a clinicopathologic, staging, and prognostic assessment J Clin Oncol 18 3794 3803
75. EL Spurrell C Fisher JM Thomas IR Judson 2005 Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital Ann Oncol 16 437 444
76. Y Sun D Gao Y Liu J Huang S Lessnick S Tanaka 2006 IGF2 is critical for tumorigenesis by synovial sarcoma oncoprotein SYT-SSX1 Oncogene 25 1042 1052
77. E Tamborini L Bonadiman A Greco A Gronchi C Riva R Bertulli PG Casali MA Pierotti S Pilotti 2004 Expression of ligand-activated KIT and platelet-derived growth factor receptor beta tyrosine kinase receptors in synovial sarcoma Clin Cancer Res 10 938 943
78. J Terry T Saito S Subramanian C Ruttan CR Antonescu JR Goldblum E Downs-Kelly CL Corless BP Rubin M van de Rijn M Ladanyi TO Nielsen 2007 TLE1 as a diagnostic immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies Am J Surg Pathol 31 240 246
79. C Thaete D Brett P Monaghan S Whitehouse G Rennie E Rayner CS Cooper G Goodwin 1999 Functional domains of the SYT and SYT-SSX synovial sarcoma translocation proteins and co-localization with the SNF protein BRM in the nucleus Hum Mol Genet 8 585 591
80. O Tureci YT Chen U Sahin AO Gure C Zwick C Villena S Tsang G Seitz LJ Old M Pfreundschuh 1998 Expression of SSX genes in human tumors Int J Cancer 77 19 23
81. M van de Rijn FG Barr MH Collins QB Xiong C Fisher 1999 Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma Am J Clin Pathol 112 43 49
82. T Watanabe M Tsuda Y Makino S Ichihara H Sawa A Minami N Mochizuki K Nagashima S Tanaka 2006 Adaptor molecule Crk is required for sustained phosphorylation of Grb2-associated binder 1 and hepatocyte growth factor-induced cell motility of human synovial sarcoma cell lines Mol Cancer Res 4 499 510
83. Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors. 4th Ed. St Louis: Mosby, Inc; 2001.
84. Y Xie B Skytting G Nilsson B Brodin O Larsson 1999 Expression of insulin-like growth factor-1 receptor in synovial sarcoma: association with an aggressive phenotype Cancer Res 59 3588 3591
85. BP Zambrowicz A Imamoto S Fiering LA Herzenberg WG Kerr P Soriano 1997 Disruption of overlapping transcripts in the ROSA beta geo 26 gene trap strain leads to widespread expression of beta-galactosidase in mouse embryos and hematopoietic cells Proc Natl Acad Sci USA 94 3789 3794